Nirmal Vasant Mulye
About Nirmal Vasant Mulye
Data last updated:
Nirmal Vasant Mulye has 25 years in corporate governance. Formerly with 6 companies, such as Pen&Paper Creative Content Private Limited and Bombay Bio-Research Centre Private Limited. Engaged in General Business, Technology and more. Contributes to corporate operations.
Current companies
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Pen&Paper Creative Content Private Limited U74999MH2019PTC334657 | Director | 18 Dec 2019 | 2019 | Active |
| Bombay Bio-Research Centre Private Limited U74120MH2011PTC224950 | Director | 20 Dec 2011 | 2011 | Active |
| Nostrum Technologies Private Limited U72900MH2007PTC173481 | Director | 01 Oct 2007 | 2007 | Active |
 Nli Healthcare (India) Private Limited U24304MH2019FTC321281 | Director | 15 Feb 2019 | 2019 | Active |
| Symmetrix Biotech Private Limited U24239MH2007PTC167239 | Director | 16 Jun 2009 | 2007 | Active |
| Enem Nostrum Remedies Private Limited U24229MH2001PTC130260 | Director | 14 Aug 2001 | 2001 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirmal Vasant Mulye
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmal Vasant Mulye
Nirmal Vasant Mulye has 25 years in corporate governance. Formerly with 6 companies, such as Pen&Paper Creative Content Private Limited and Bombay Bio-Research Centre Private Limited. Engaged in General Business, Technology and more. Contributes to corporate operations.
Nirmal Vasant Mulye is associated with 0 companies as a director.
Nirmal Vasant Mulye has expertise in General Business, Technology and other sectors.
Nirmal Vasant Mulye has 25 years in corporate governance.